Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 388

1.

Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.

Awodele O, Aliu R, Ali I, Oni Y, Adeyeye CM.

Pharmacol Res Perspect. 2018 Oct;6(5):e00427. doi: 10.1002/prp2.427.

2.

Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor.

Valkovic AL, Leckey MB, Whitehead AR, Hossain MA, Inoue A, Kocan M, Bathgate RAD.

Pharmacol Res Perspect. 2018 Sep 24;6(5):e00432. doi: 10.1002/prp2.432. eCollection 2018 Oct.

3.

Methods for the assessment of selection bias in drug safety during pregnancy studies using electronic medical data.

Schnitzer ME, Blais L.

Pharmacol Res Perspect. 2018 Sep 21;6(5):e00426. doi: 10.1002/prp2.426. eCollection 2018 Oct.

4.

Corrigendum.

[No authors listed]

Pharmacol Res Perspect. 2018 Sep 17;6(5):e00429. doi: 10.1002/prp2.429. eCollection 2018 Oct.

5.

14,15-epoxyeicosatrienoic acid produced by cytochrome P450s enhances neurite outgrowth of PC12 and rat hippocampal neuronal cells.

Oguro A, Inoue T, Kudoh SN, Imaoka S.

Pharmacol Res Perspect. 2018 Sep 17;6(5):e00428. doi: 10.1002/prp2.428. eCollection 2018 Oct.

6.

Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes.

Dissanayake AM, Wheldon MC, Hood CJ.

Pharmacol Res Perspect. 2018 Sep 14;6(5):e00424. doi: 10.1002/prp2.424. eCollection 2018 Oct.

7.

Elevated 4β-hydroxycholesterol/cholesterol ratio in anorexia nervosa patients.

Hole K, Heiberg PL, Gjestad C, Mehus LL, Rø Ø, Molden E.

Pharmacol Res Perspect. 2018 Sep 11;6(5):e00430. doi: 10.1002/prp2.430. eCollection 2018 Oct.

8.

Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations.

Monteiro JF, Hahn SR, Gonçalves J, Fresco P.

Pharmacol Res Perspect. 2018 Jul;6(4):e00420. doi: 10.1002/prp2.420.

9.

Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models.

Sampson CM, Kasper JM, Felsing DE, Raval SR, Ye N, Wang P, Patrikeev I, Rytting E, Zhou J, Allen JA, Hommel JD.

Pharmacol Res Perspect. 2018 Aug 23;6(5):e00425. doi: 10.1002/prp2.425. eCollection 2018 Oct.

10.

Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies.

Brown K, Mendell J, Ohwada S, Hsu C, He L, Warren V, Dishy V, Zahir H.

Pharmacol Res Perspect. 2018 Aug 23;6(5):e00418. doi: 10.1002/prp2.418. eCollection 2018 Oct.

11.

Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in Eritrea.

Russom M, Debesai M, Zeregabr M, Berhane A, Tekeste T, Teklesenbet T.

Pharmacol Res Perspect. 2018 Jul 31;6(4):e00423. doi: 10.1002/prp2.423. eCollection 2018 Jul.

12.

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum.

Iwamoto N, Yokoyama K, Takanashi M, Yonezawa A, Matsubara K, Shimada T.

Pharmacol Res Perspect. 2018 Jul 24;6(4):e00422. doi: 10.1002/prp2.422. eCollection 2018 Jul.

13.

Screening of anticancer drugs to detect drug-induced interstitial pneumonia using the accumulated data in the electronic medical record.

Shimai Y, Takeda T, Okada K, Manabe S, Teramoto K, Mihara N, Matsumura Y.

Pharmacol Res Perspect. 2018 Jul 12;6(4):e00421. doi: 10.1002/prp2.421. eCollection 2018 Jul.

14.

Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6, CYP2B6, and CYP3A4 genotype.

Haage P, Kronstrand R, Josefsson M, Calistri S, van Schaik RHN, Green H, Kugelberg FC.

Pharmacol Res Perspect. 2018 Jul 5;6(4):e00419. doi: 10.1002/prp2.419. eCollection 2018 Jul.

15.

Drug conjugates-an emerging approach to treat breast cancer.

Hasan M, Leak RK, Stratford RE, Zlotos DP, Witt-Enderby PA.

Pharmacol Res Perspect. 2018 Jul 5;6(4):e00417. doi: 10.1002/prp2.417. eCollection 2018 Jul.

16.

Potential role for histone deacetylation in chronic diazepam-induced downregulation of α1-GABAA receptor subunit expression.

Auta J, Gatta E, Davis JM, Pandey SC, Guidotti A.

Pharmacol Res Perspect. 2018 Jun 26;6(4):e00416. doi: 10.1002/prp2.416. eCollection 2018 Jul.

17.

The G protein-coupled estrogen receptor agonist, G-1, attenuates BK channel activation in cerebral arterial smooth muscle cells.

Evanson KW, Goldsmith JA, Ghosh P, Delp MD.

Pharmacol Res Perspect. 2018 Jun 21;6(4):e00409. doi: 10.1002/prp2.409. eCollection 2018 Jul.

18.

The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects.

Johnson M, Jewell RC, Peppercorn A, Gould E, Xu J, Lou Y, Davies M, Baldwin S, Tenorio AR, Burke M, Jeffrey J, Johns BA.

Pharmacol Res Perspect. 2018 Jun 5;6(4):e00408. doi: 10.1002/prp2.408. eCollection 2018 Jul.

19.

Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence.

Yadlapalli JSK, Bommagani SB, Mahelona RD, Wan A, Gannon BM, Penthala NR, Dobretsov M, Crooks PA, Fantegrossi WE.

Pharmacol Res Perspect. 2018 Jun 19;6(4):e00403. doi: 10.1002/prp2.403. eCollection 2018 Jul.

20.

No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart.

Weinberger F, Nicol P, Starbatty J, Stubbendorff M, Becher PM, Schrepfer S, Eschenhagen T.

Pharmacol Res Perspect. 2018 Jun;6(3):e00407. doi: 10.1002/prp2.407.

Supplemental Content

Loading ...
Support Center